top of page

Femara 2.5 mg Tablet

SKU Novartis India Ltd
Original price

$3.72

Sale price

$3.29

Femara 2.5 mg Tablet is an effective medication classified as an aromatase inhibitor, primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By blocking the aromatase enzyme, Femara significantly reduces estrogen production in the body, which is crucial for the growth of certain types of breast tumors. This targeted approach not only aids in shrinking existing tumors but also plays a vital role in reducing the risk of cancer recurrence after initial treatment. Patients should be aware of potential side effects, which may include hot flashes, fatigue, and joint pain, and it is essential to consult a healthcare provider for guidance on monitoring and managing these effects. It is important to inform your doctor of any pre-existing health conditions or medications being taken, as they may influence the safety and efficacy of Femara. With its proven track record in cancer management, Femara is an important option for those navigating the complexities of breast cancer treatment. As with any medication, adherence to the prescribed dosage and regular follow-up appointments are crucial for achieving the best outcomes in cancer care.

Quantity

Active Pharmaceutical Ingredient

Letrozole 2.5 mg

Uses

• Femara •5 mg tablet is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It helps lower estrogen levels in the body, which can slow or stop the growth of certain types of breast tumors. By inhibiting aromatase, Femara •5 mg tablet effectively reduces the recurrence of cancer after surgery. This medication is often prescribed following initial treatment to enhance long-term outcomes.
• In addition to its role in treating existing breast cancer, Femara •5 mg tablet is also utilized in adjuvant therapy. This means it is given after surgery to help prevent cancer from returning. The medication is particularly beneficial for patients with early-stage breast cancer who have undergone lumpectomy or mastectomy. Femara •5 mg tablet supports a comprehensive treatment plan by addressing potential residual disease.
• Femara •5 mg tablet can be beneficial in cases where breast cancer has metastasized to other parts of the body. It helps manage advanced breast cancer by significantly lowering estrogen levels, which can fuel tumor growth. This approach may improve the quality of life for patients dealing with metastatic disease. By incorporating Femara •5 mg tablet into their treatment regimen, patients may experience better disease control.
• Healthcare providers may also recommend Femara •5 mg tablet as a preventive measure for women at high risk of developing breast cancer. This includes those with a family history or genetic predisposition to the disease. By reducing estrogen production, Femara •5 mg tablet aims to decrease the likelihood of cancer development in these individuals. This proactive use underscores the medication's versatility in breast cancer management.

Benefits

Femara 2.5 mg Tablet belongs to a class of drugs called aromatase inhibitors. It inhibits the enzyme aromatase, which plays a crucial role in the production of estrogen. By blocking aromatase, Femara 2.5 mg effectively lowers estrogen levels, which is beneficial in hormone-dependent breast cancers. Femara 2.5 mg Tablet is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It helps to slow down or stop the growth of breast cancer cells by reducing the levels of estrogen in the body. Femara 2.5 mg Tablet can improve disease-free survival rates in postmenopausal women with hormone receptor-positive breast cancer when compared to other hormonal therapies. Femara 2.5 mg Tablet is commonly used as adjuvant therapy after surgery or other primary treatments for breast cancer. It helps to reduce the risk of cancer recurrence and improves the chances of long-term remission. Femara 2.5 mg has also been explored for off-label uses, such as fertility treatment in women with polycystic ovary syndrome (PCOS) who are trying to conceive. In such cases, Femara 2.5 mg Tablet helps induce ovulation by suppressing estrogen production. It's important to note that while Femara 2.5 mg Tablet has several benefits, it should only be used under the guidance of a healthcare professional. The appropriate use of Femara 2.5 mg Tablet depends on individual factors and should be discussed with a qualified medical practitioner.

Side Effects

Like all medication, Femara 2.5 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects

• High Blood Pressure
• Hot Flashes
• Vomiting
• Diarrhoea
• Hair Thinness
• Weight Gain
• Vaginal Dryness
• Appetite Loss
• Skin Dryness
• High Levels of Cholesterol
• Pain in Muscles and Bones
• Swelling

Common Side Effects

• Coughing of Blood
• Fainting
• Liver Inflammation
• Breathlessness
• Vision Changes
• Allergic Reactions
• Fainting

How To Use

Femara 2.5 mg Tablet can be taken with or without food. Try to take your Femara 2.5 mg at the same time each day. You can choose a time that suits your everyday routine. This will make it easier to remember to take your medicine. Swallow the tablet whole with a drink of water. Do not crush or chew it. If you forget a dose take it as soon as you remember, unless your next dose is due in 2 or 3 hours. In this case, skip the missed dose and take your next one at the usual time. Do not take a double dose to make up for a forgotten dose.

Safety Advice

• Alcohol: It is not recommended to consume alcohol while taking Femara 2.5 mg Tablet. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Femara 2.5 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Femara 2.5 mg Tablet is safe for use in kidney disease patients. No dosage adjustment is required for kidney patients with creatinine clearance greater than 10 mL/min. Please consult your doctor if you have kidney impairment or any concerns.
• Breastfeeding: It is not recommended to breastfeed while taking Femara 2.5 mg. Femara 2.5 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Femara 2.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Femara 2.5 mg Tablet is safe for mild to moderate liver disease patients. No dosage adjustment is required for mild to moderate liver disease patients. In severe liver disease, patients are used with caution. Dose adjustment of Femara 2.5 mg may be needed. Please consult your doctor.
• Pregnancy: Use of Femara 2.5 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Femara 2.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Femara 2.5 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Femara 2.5 mg.

bottom of page